ÌÇÐÄÊÓÆµ

Mothaffar F. Rimawi

Rimawi

Mothaffar F. Rimawi, M.D.

Professor

(832) 957-6500

Positions

Professor
Department of Medicine
Section of Hematology and Oncology
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas, United States
Executive Medical Director
Dan L Duncan Comprehensive Cancer Center
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas, United States
Associate Director for Clinical Affairs
Dan L Duncan Comprehensive Cancer Center
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas, United States
Philip A. Salem, M.D. Chair in Cancer Research
Baylor St. Luke's Medical Center
Houston, Texas, United States

Addresses

Dan L Duncan Comprehensive Cancer Center (Clinic)
Dan L Duncan Comprehensive Cancer Center
1919 Old Spanish Trail
Houston, TX, 77054
United States
Phone: (832) 957-6500
Fax: (713) 610-4595
rimawi@bcm.edu
McNair Campus (Office)
Dan L Duncan Comprehensive Cancer Center
1919 Old Spanish Trail
Houston, TX, 77054
United States
Phone: (713) 798-1311
rimawi@bcm.edu

Education

MD from University Of Jordan
06/1997 - Amman, Jordan
Residency at ÌÇÐÄÊÓÆµ Of Medicine
08/2001 - Houston, Texas, United States
Internal Medicine
Fellowship at ÌÇÐÄÊÓÆµ Of Medicine
11/2004 - Houston, Texas, United States
Medical Oncology and Hematology
Fellowship at ÌÇÐÄÊÓÆµ Of Medicine
05/2005 - Houston, Texas, United States
Breast Cancer

Certifications

Board Certified-Medical Oncology
(11/01/2014)
American Board of Internal Medicine
Board Certified-Internal Medicine
(12/29/2011)
American Board of Internal Medicine

Professional Interests

  • Management of Breast Cancer
  • Clinical Trials in Breast Cancer
  • Neoadjuvant Therapy
  • Targeted therapy and Biomarkers in Breast Cancer.
  • HER2-positive Breast Cancer
  • Locally advanced breast cancer
  • Treatment Resistance

Professional Statement

I am a board certified medical oncologist specializing in breast cancer care and research. I am the Executive Medical Director of the Dan L Duncan Comprehensive Cancer Center.
My research is focused on translating laboratory findings to the clinic to develop new treatments for breast cancer, and then taking clinical findings and materials back to the lab to study them with other scientists. Related to that, my team’s work has been pivotal in treatment optimization for HER2+ Breast Cancer, endocrine therapy for ER+ Breast Cancer, and new targeted therapy for Triple Negative Breast Cancer.
I dream of a world free of the pain and suffering of breast cancer and work tirelessly every day towards making that dream a reality.

Videos

Mothaffar F. Rimawi, M.D. is board certified in internal medicine, hematology and medical oncology.

Memberships

American College of Physicians
Member
American Society of Clinical Oncology
Member
American Association for Cancer Research

Languages

Arabic

to edit your profile